Ten-year kidney transplant survival of cyclosporine- or tacrolimus-treated patients in Brazil

Descrição

Tipo

Artigo de periódico

Título alternativo

Primeiro orientador

Membros da banca

Resumo

Background: Cyclosporine and tacrolimus are well established immunosuppressants; however little know about long term survival rates. Aim: Compare 10-year graft survival and associated factors among kidney transplant patients within the Brazilian Public Health system (SUS) prescribed either medicine. Methods: Analyze a national cohort of kidney transplant recipients within SUS. Graft loss defined by death or dialysis for more than three months. Kaplan-Meier method used to estimate cumulative probabilities of survival. Cox proportional hazards modelused to evaluate factors associated with progression to graft loss. Results: 13,811 patients were included, 5,887 used cyclosporine and 7,924 tacrolimus. A higher risk of graft loss was associated with tacrolimus, a deceased donor, additional years of age, median period of dialysis greater than 47 months, diagnosis of diabetes as the primary cause of chronic kidney disease and transplantation between 2005 and 2009. Conclusions: Among other factors, tacrolimus based regimens were associated with worse graft survival.

Abstract

Assunto

Transplante de Rim, Análise de Sobrevida, Ciclosporina, Estimativa de Kaplan-Meier

Palavras-chave

Kidney Transplantation, survival analysis, Cyclosporine

Citação

Curso

Endereço externo

https://www.tandfonline.com/doi/abs/10.1080/17512433.2016.1190270

Avaliação

Revisão

Suplementado Por

Referenciado Por